D.H.E. 45 Dosage
Generic name: Dihydroergotamine Mesylate 1mg in 1mL
Dosage form: injection, solution
Drug class: Antimigraine agents
Medically reviewed by Drugs.com. Last updated on Mar 24, 2025.
D.H.E. 45 (dihydroergotamine mesylate) Injection, USP should be administered in a dose of 1 mL intravenously, intramuscularly or subcutaneously. The dose can be repeated, as needed, at 1-hour intervals to a total dose of 3 mL for intramuscular or subcutaneous delivery or 2 mL for intravenous delivery in a 24-hour period. The total weekly dosage should not exceed 6 mL. D.H.E. 45 (dihydroergotamine mesylate) Injection, USP should not be used for chronic daily administration.
Frequently asked questions
More about D.H.E. 45 (dihydroergotamine)
- Check interactions
- Compare alternatives
- Reviews (10)
- Side effects
- During pregnancy
- Drug class: antimigraine agents
- Breastfeeding
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.